tiprankstipranks
9 Meters Biopharma, Inc. (NMTRQ)
:NMTRQ
US Market

9 Meters Biopharma (NMTRQ) Financial Statements

Compare
1,968 Followers

9 Meters Biopharma Financial Overview

9 Meters Biopharma's market cap is currently $14.00. The company's EPS TTM is $; its P/E ratio is ―; 9 Meters Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement
Total Revenue
Gross Profit-----
Operating Income$ -42.02M$ -36.76M$ -60.88M$ -25.58M$ -18.22M
EBITDA$ -39.30M$ -36.72M$ -57.43M$ -24.21M$ -15.48M
Net Income$ -43.77M$ -36.78M$ -61.50M$ -27.13M$ -24.16M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 33.10M$ 50.17M$ 39.16M$ 5.30M$ 6.45M
Total Debt$ 19.73M$ 167.94K$ 230.78K$ 3.23M$ 5.20M
Net Debt$ 7.13M$ -46.83M$ -37.70M$ -1.44M$ -607.23K
Total Liabilities$ 30.75M$ 8.57M$ 7.02M$ 14.91M$ 10.11M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -37.25M$ -29.49M$ -19.41M$ -17.90M$ -15.18M
Operating Cash Flow$ -37.24M$ -29.48M$ -19.41M$ -17.89M$ -15.17M
Investing Cash Flow
Financing Cash Flow
Currency in USD

9 Meters Biopharma Earnings and Revenue History

9 Meters Biopharma Debt to Assets

9 Meters Biopharma Cash Flow

9 Meters Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis